Chicago Partners Investment Group LLC Novavax Inc Transaction History

Chicago Partners Investment Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$69.73 - $142.9 $207,655 - $425,556	-2,978 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$134.56 - $217.97 $29,872 - $48,389	-222 Reduced 6.94%	2,978 $239,000
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $369,112 - $561,724	-2,076 Reduced 39.35%	3,200 $663,000
Q2 2021 Aug 02, 2021	BUY	$121.0 - $257.67 $261,723 - $557,340	2,163 Added 69.48%	5,276 $1.02 Million
Q1 2021 Apr 28, 2021	BUY	$112.98 - $319.93 $147,551 - $417,828	1,306 Added 72.27%	3,113 $690,000
Q4 2020 Jan 27, 2021	BUY	$78.74 - $139.5 $142,283 - $252,076	1,807 New	1,807 $229,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.